Her husband Jiang Shibo is a futures tycoon, and his wife Gao Yaping once praised Jinshi Asian Medicine and lurked in Meiliyun. The "couple and wife" is widely involved in industrial investment and primary and secondary markets.

Editorial Department of this magazine | Qi Yongchao

Husband Jiang Shibo is an Futures tycoon. His wife Gao Yaping once held a bid for Jinshi Sub-Pharm and lurking Meiliyun and is well-known. The Niu San "couple file" is widely involved in industrial investment and primary and secondary markets.

In addition, the mysterious "Qianzhan Series" behind Gao Yaping and Jiang Shibo is worth mentioning. Its "marathon"-style holdings can always accurately bet on bull stocks.

In a recent private placement by a listed company, Gao Yaping's name appeared again. What kind of "chain reaction" will this trigger?

Gao Yaping "appeared" to private placement The target stock "responsively" started to rise against the market

As a "super bull spoil", Gao Yaping's recent move to build a position in Titan Technology has attracted market attention.

According to the results of the private placement released by Titan Technology on August 23, the private placement issued 7.625 million shares of shares at an issue price of 131.61 yuan per share, with a total fundraising of 1.004 billion yuan, and the lock-up period is 6 months. "Red Weekly" noticed that among the 17 finalized issuance targets, three individual investors participated, one of which was Gao Yaping.

However, Gao Yaping's purchase amount is the smallest, with a total of 72,300 shares allocated, which is only 4.7% of the allocated amount of the first place ( GF Securities ), and the cost is less than 10 million yuan, which is about 9.5133 million yuan (see Table 1).

Table 1: Gao Yaping’s private placement Titan Technology

Data source: Wind

From the historical data, there are few cases of Gao Yaping’s stock investment through private placement. In addition to Titan Technology, which has participated in recently, the earlier cases that can be found are the private placement of Dagang Shares , which it participated in in 2019.

But Gao Yaping chose the bull stock, but failed to "take off" with the bull stock.

Wind data shows that Gao Yaping participated in the subscription of 6.2732 million shares of Dagang Co., Ltd. and was approved for ban on May 31, 2019. However, from the perspective of subsequent holdings, Gao Yaping started a reduction model after the ban was lifted. As the shareholders' holdings of the top ten circulating shares as of the 2019 interim report, Gao Yaping's holdings have dropped to 2.1375 million shares. The third quarter report of 2019 has withdrawn from the list of shareholders of the top ten circulating shares. But a few years later, Dagang Co., Ltd. has transformed into a super dark horse. For example, from May to August 2022, it was speculated because it "accompanies" the popular Chiplet concept at that time. In the short term, the stock price achieved an increase of up to 3 times (see Figure 1).

Figure 1: Gao Yaping's stock price performance after participating in the private placement of Dagang shares

Data source: Wind

However, Gao Yaping's "inclusive increase effect" seems to have also occurred in Titan Technology.

After completing the private placement on August 23, Titan Technology's stock price began to stop falling and rose against the market. As of September 14, the cumulative increase reached 9.30%, while the Science and Technology Innovation 50 Index fell 6.86% during the same period. In addition, if we look at the issuance price of 131.61 yuan for the fixed-increase of 153.79 yuan for closing price of , the yield is about 16.85%, and the floating profit is about 1.6 million yuan.

Like "marathon" holdings The longest holding cycle is 9 years

Gao Yaping has been active in the capital market for the past ten years and has long been famous. According to relevant information, Gao Yaping's current address is Hangzhou. Judging from the market value of the stocks she holds, her value is nearly 2 billion. Her husband Jiang Shibo is definitely not an ordinary person. Jiang Shibo has the title of China's super bull and futures tycoon, and is also a bull in the stock market.

Judging from the historical holding styles of Gao Yaping and Jiang Shibo, they have given a "Masong style" extremely long-term treatment to most targets.

Judging from the newly disclosed shareholder positions of listed companies in the second quarter, Gao Yaping appeared in the top ten circulating shareholders of 8 stocks, with a total holding of 1.903 billion yuan. Among the shares held by it, except for a slight reduction in holdings of Hailanxin, the other 7 stocks, including Jinshi Asia Pharmaceutical, Keliyuan , Qianjiang Motorcycle , and Meiliyun, are all "unchanged".

is basically the same as Gao Yaping's style. Judging from the holdings in the second quarter of this year, Jiang Shibo appeared in the top ten circulating shareholders of 7 stocks, with a total holding market value of approximately RMB 913 million. Among the individual stocks it holds, except for the slightly increased Guangyuyuan , the number of other six individual stocks including Meiliyun, Zhengmeiji, etc., which hold html (see Table 2).

Table 2: Gao Yaping and Jiang Shibo's holdings in the second quarter

Data source: Wind

It is different from other bull "couple-wife" such as Xia Chongyang and Zhang Sufen, which have shorter holdings . Gao Yaping and Jiang Shibo's holdings cycles are significantly longer. years is the "starting holding time", and many individual stocks hold positions for more than 5 years.

, such as Gao Yaping's holdings, has become the top ten shareholders of the company's circulating shares since its 2013 annual report. It has been holding positions until its interim report in 2022, with a continuous position for 35 quarters, nearly 9 years. In addition, the Qianjiang Motorcycle, Meli Cloud, and ,000 IXUANG they held were mostly newly entered into the top ten circulating shareholders from 2015 to 2016. They have also held positions for more than 5 years so far. In the interim report in 2018, Jinshi Asia Pharmaceutical, which has newly entered into the top ten circulating shareholders, has also held positions for more than 4 years (see Table 3). Many of the individual stocks held by Jiang Shibo also became the top ten shareholders of the company's top ten circulating shares in 2015 or 2016, and are still holding them for a long time, such as Melly Cloud.

Table 3: Gao Yaping's long-term holdings stocks (partial)

Data source: Wind

t ml1Gao Yaping and Jiang Shibo "cooperated" stocks mostly ushered in a "continuous board" surge

However, the results of long-term holdings have not all obtained excess returns, and the performance of many individual stocks is also uneven. "Red Weekly" noticed that some of the targets held by Gao Yaping and Jiang Shibo for a long time had held positions for several years but the stock price had been on a "roller coaster", while others were trapped. In addition, the "extreme" situation was that some companies "buy more and more" and eventually became major shareholders. However, the stocks that the two "cooperated" in the layout have shown several impressive performances...

trading Qianjiang Motorcycle "lose time and lose troops."

Wind data shows that Gao Yaping became the fourth largest shareholder of Qianjiang Motorcycle's circulating stock in the 2016 interim report as a new addition. She held 3.4822 million shares at that time, and then continued to increase her holdings to 13.9281 million shares from the 2016 third quarter report to the 2017 third quarter report. In the interim report of the fourth quarter of 2017-2022, the number of shares held overall has not changed. Qianjiang Motorcycle's stock price returned to the starting point after a double increase from June to October 2020. Gao Yaping's holdings in the third quarter of 2017 were 240 million yuan, and at the end of the second quarter of this year, it was still 240 million yuan.

There are also cases where you are trapped by chasing highs. For example, Wanxun Automation, Gao Yaping became the second largest shareholder of the company's circulating stock at the bull market high in the second quarter of 2015. At that time, she held 6.0223 million shares and had a market value of 133 million yuan. Wanxun Automation's stock price was also at a historical high at that time. From then on to the 28 quarters of the second quarter of 2022, the company's stock price was "halved", and Gao Yaping's "unchangeable" holdings were all the way, and the market value of the holdings shrank to 61 million yuan.

Jinshi Asian Medicine is a case where Gao Yaping continuously increased her positions and became the largest shareholder. At the end of the second quarter of this year, Gao Yaping held 100.8789 million shares, with a market value of 994 million yuan, accounting for 25.11% of the total share capital, ranking first as the largest shareholder.It is worth mentioning that unlike other targets that are directly purchased in the secondary market, since the initial position was established, Gao Yaping "directly connects" with the controlling shareholders of Jinshi Yaya Pharmaceutical. Since 2018, Gao Yaping has acquired the shares held by the controlling shareholders and others in the form of transfer agreements many times.

At present, Jinshi Asia Pharmaceutical is Gao Yaping's largest heavy-weight stock and the company with the highest holding ratio. So, Gao Yaping keeps "buying, buying, buying, and "going to the top as she wishes", what is the purpose? This may be related to its "parabi" towards pharmaceutical stocks. "Red Weekly" noticed that Gao Yaping not only directly holds shares in pharmaceutical listed companies, but also owns shares in many non-listed pharmaceutical companies . Some analysts said that this move is to pave the way for other pharmaceutical companies to go public.

Judging from the latest second quarter holdings, Gao Yaping and Jiang Shibo also hold multiple stocks at the same time, such as Haite Biologics , Meliyun, Zhejiang Heideman, etc. "Coincidentally", after Gao Yaping and Jiang Shibo "changed", many companies ushered in the "continuous board" performance of their stock prices.

Figure 2: Jiang Shibo's stock price performance after entering Haite Biotechnology

Data source: Wind

Jiang Shibo became the top ten circulating shareholder of Haite Biotechnology in the interim report in 2019. At that time, he held 2.067 million shares and a market value of 62 million yuan; in the first quarter of 2020, Gao Yaping became the top ten circulating shareholder of the company, holding 1.033 million shares. In the first quarter of 2020, Haite Bio's stock price surged. For example, from February 28 to March 12, the stock price closed for 10 consecutive boards, with a range increase of 160.2% (see Figure 2).

The mysterious "Qianzhan system" behind the movements frequently

The most New has "locked" multiple "targets"

In fact, Gao Yaping and Jiang Shibo are not only active in the secondary market, but also widely involved in industrial investment, primary market and other fields . With the two as the core, behind it is a powerful mysterious power - the "Qianzhan Series".

It has to be mentioned that before, some media questioned that a listed company was manipulated by the "Qianzhan Group", which once attracted the attention of regulators. However, institutions with the word "Qianzhan" rarely appear directly on the list of shareholders of listed companies, but appear in the form of a "mysterious person" behind the "Qianzhan Group". Due to the complex relationship, it is inevitable that it has a "mysterious" tone.

Currently, Gao Yaping is the largest shareholder and core person of Zhejiang Qianzhan Investment Management Co., Ltd. (hereinafter referred to as "Zhejiang Qianzhan Investment"), and the legal person is Ye Maoyang. In addition, with Jiang Shibo and Gao Yaping as the core, a number of investment companies with the word "Qianzhan" were established.

"Red Weekly" is not completely sorted out. As of the second quarter of this year, Gao Yaping, Jiang Shibo and other personnel related to the "Qianzhan Group" such as Ye Maoyang, Shen Xianglong (Shanghai Qianzhan Asset Legal Person), Liu Yichao (Shanghai Qianzhan Asset Executive), etc. also appeared on the list of shareholders of the top ten circulating shares of many companies such as Zhejiang Heideman, Qianjiang Motorcycle, and Keliyuan.

So, as the "Qianzhan Group" behind Gao Yaping and Jiang Shibo, what new actions have been made recently?

"Red Weekly" noticed that since this year, the "Qianzhan Group" has become extremely active in institutional surveys of listed companies...

According to incomplete statistics of Wind data, since this year, Zhejiang Qianzhan Investment has appeared in the survey list of 10 companies. There are not many "10 companies", but this is the most surveyed in recent years. In comparison, from 2019 to 2021, the number of companies surveyed by Zhejiang Qianzhan Investment was only 1 ( Midea Group ), 1 ( Mindray Medical ) and 5 (Hexing Co., Ltd., Cos Technology, Qiaqia Food , Ocean King , and Central Control Technology).

Judging from the research targets of Zhejiang Qianzhan Investment, health care and automotive parts are its "favorites".For example, among the 10 stocks it surveyed, two belong to the healthcare industry, such as Lepu Medical and Aibo Medical; about 3 are automotive parts concept stocks , such as Keboda , Huayang Group , double-ring transmission , etc. (see Table 3).

Table 3: Research status of Zhejiang Qianzhan Investment this year

Data source: Wind, data As of September 16

In addition, another company of the "Qianzhan Group" Shanghai Qianzhan Assets has also increased its research frequency this year. Wind data shows that Shanghai Qianzhan Asset has surveyed 33 listed companies this year, among which pharmaceutical companies are its favorite (see Table 4).

Table 4: Research status of Shanghai Qianzhan Asset this year

Data source: Wind, data As of September 16

It is obvious that behind the "Qianzhan Group"'s active search for investment targets is Gao Yaping and Jiang Shibo's "preliminary work". So, which companies will become the targets of their two people? "Red Weekly" is willing to pay attention to and witness with investors.

(The individual stocks mentioned in the article are for example analysis only, and no recommendations for trading are made.)